Tenax Therapeutics TENX
NASDAQ TENX
$1.89 +0.05 (+2.72%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Restructuring Costs (2012 - 2013)

Updated

Tenax Therapeutics (TENX) reported Restructuring Costs of $220,715 for FY2013.

Analysis

Tenax Therapeutics (TENX) Restructuring Costs (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tenax Therapeutics 85.48 Mn 85.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2013 2,941.00
Oct 31, 2012 170,298.00
Jul 31, 2012 47,476.00
API Access

Tenax Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=TENX&period=max&api_key=YOUR_API_KEY